FindTrial
Sign In

A Comparative Clinical Study Of Q-Switched Nd:YAG Laser And Arginine Lactic Acid Peel In The Management Of Periorbital Melanosis

Illuminating The Eyes: A Comparative Clinical Study Of Q-Switched Nd:YAG Laser And Arginine Lactic Acid Peel In The Management Of Periorbital Melanosis - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/112014
Enrollment
30
Registered
2026-06-05
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L818- Other specified disorders of pigmentation

Interventions

Intervention1: ND YAG LASER: -Laser type: Q-switched Nd: YAG laser (1064 nm) -Spot size: 6 mm -Fluence: 1.5 3.0 J/cm -Frequency: 5 Hz -Technique: -Protective eye shields will be placed. -Multiple s

Sponsors

JJM Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -Age 18 45 years -Both genders -Clinically diagnosed periorbital melanosis (grades 2 4 based on POM severity scale) -Fitzpatrick skin types III V

Exclusion criteria

Exclusion criteria: -Pregnancy or lactation -Active dermatitis or infection in the periorbital area -Use of depigmenting agents or peels in the last 3 months -History of keloid tendency or photosensitivity

Design outcomes

Primary

MeasureTime frame
-To compare the efficacy of Q-switched Nd:YAG laser versus arginine lactic acid peel in reducing periorbital pigmentation.Timepoint: Baseline,12 weeks—

Secondary

MeasureTime frame
-To assess patient satisfaction & quality of life improvement post-treatment. -To evaluate side effects & safety profiles of both modalities.Timepoint: baseline,12 weeks—

Countries

India

Contacts

Public ContactAishwarya B N

JJM Medical College

drhcmangala@gmail.com9886075467

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026